pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-137 |
Genomic Coordinates | chr1: 98046070 - 98046171 |
Description | Homo sapiens miR-137 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-137 |
Sequence | 59| UUAUUGCUUAAGAAUACGCGUAG |81 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | AGO4 | ||||||||||||||||||||
Synonyms | EIF2C4 | ||||||||||||||||||||
Description | argonaute 4, RISC catalytic component | ||||||||||||||||||||
Transcript | NM_017629 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on AGO4 | |||||||||||||||||||||
3'UTR of AGO4 (miRNA target sites are highlighted) |
>AGO4|NM_017629|3'UTR 1 GAGTCTCAGAAAAAGAACTCAACCAATTTGGCACCCCATGCAGCCTCAAAATGTTTCAAATGCCTACCGCCTCTAGATCG 81 AGCCACGTTGACTTCAGGTGGTCTTCTACCAGCAGCTCGGAATAGTTGCACTGAATCTATACTTTGCAGCACTGTCTGAT 161 GCGTCAACAAAATTGAGCCATTTTTTTAAAGTAATAGATACTAATAGATTATCTTTTCTGATGCACTGGACTGAATTTTT 241 ACCTCAATGTGCAAAGGCTGATCAGCCTGAACTTTCTAAAGGACTTTACAAGAAGGGTTTCTATGGAATATTTTGCTAGC 321 TGTGGTGTTCACCGCATCCCTCTAGTCTTAGAAGAGAAGATTATTCCTTTTTTCTGTAGTCATTGAGTGGGGTATATGCA 401 TAAGTGGGAGAGAAAAACCAAACAATCTACTTCAGTTCAGTGTAACTATTTAATTGTGTGGGTCCATAGACTTTTTAATG 481 AAGATTTCTGACTTTGCCACTGTAAATGCCTTTAATGAGCATTAATTTTTGAAAGTTTTACAGAGTTTTATTAGTTTTAC 561 TACTTTATCTTATTGATCTCTGCAGACTTGTGCTGGTGCAAGTACATGCTGACAGGCAATTTGCACTATATTTGGCTGCA 641 GATTCAAATAGGCAGTTCTCTTATTTGGTCGACTTTTGTGAATGTGTGACATAAACAGATGTAATGCATGTCACAGTGAC 721 GGAGATAACACTGCCATGATAAAAGTACTCATGTTTCCCCTATTTGGAAAAAAAAATTGCTTTTAGTATTTTTCCAAGTT 801 TTCAAAAGTGCCCATTTTATGCTGCTGTGTGGTTTGTTAAATCTAAATGATTTTTAAACTTTTCTCATAGAAACTTAACT 881 TTGGCAATAAACATTTTTTAAGGTCTCTCCTCTTCCTTCCCCAACAATGTAGTTTTCTAGATGAGATTTCAGTATGATTT 961 TATCAGCTATTTCTTATATATCATAATCTGGCAATTTCTGAAACCAGTCAGAAAAGACATATATTTCCATGCCTTTTTAA 1041 AGAATTATTTTTACCTGTTTTATATTCACAGTTGGTGTCCTGTCACTTTGTTTTAAAATAAGCTAGAACCAGGATGCTTC 1121 CTTATTGGAAAGGCTTTGCCAGTCCTTAAGGTACAATGAGTGATGCTGCAACTTGCAAATGTACCAGCATTTAAAATTTC 1201 TTTTCCTGGGAATCAAGGTAACTCACACGACTACTTGCAGTACAAATTTTTTGCTTCTCTTTCGACATGAAATGTACTTG 1281 GTGGGTTTTCCTTCCTTTTATTAAACTAAAACTGTGTGGAAAAGGTTGATTTTTCTTAATAGATTCTGGATTCCACTCAC 1361 AGGGAGATGGGATTCCTTTCTTGTCCAAACAAAGGGAGTTGCTCTAAAGCGAGCATCAGTTAAAATGTAGGGGAAAATGT 1441 ATTCTGTATGTAGTGTAGATAATACTTTGTGAATGGACAACAGTTACATAGTGTCTTGGTAGCACCAGCCAGTGTTTCCC 1521 AGCCCAGAGTTTACTGACTTGTAATTCTCTATCCAGGACATCAGGAGTGAGGGATGGAAAAGGGGATAAAAGGCCTGGAG 1601 CCACACTCTATATGGCTGAGGAAGGAGCTAGGGAAAGAGATAGACACAATGGGGTGAAAACAATTTTGCCGCCCCTGCCT 1681 GGAAACTGCTGGTGGGGAAATGATGGTGAAGGGTGTTTGCTTGAACTCATGAGACGGTCCAAATCTCATAAACTAGCCTT 1761 CTCAAAATCCCAGCAATATAAAGCACTGTTTTTCTTCAGTCGTTTAAATAAACTTGTAAATACATTGAAGTTTACATTTC 1841 CATGTGCTGTTGATCAACGGCGCCACCTGTGTTTGCTGAGACTGGTCTCTGAGAGAGTTTTATGTCGATCGAGGCCTGTT 1921 GCTCATTAAGCTGAGTGCAGACGTCCTTAATCCCTGCAGATAGTGGGATGAAAGCAAGTTCTGTAAAATGAAGCACAACA 2001 TAGCCAGGAGTGAAGAGATGGCAGATGTTAATTTCTTAAAATTTTCCTTTTTTTTTTTTTTTTTTGCAAATACCTCACTT 2081 GGATAATACAAATCAGGACATGTTGGTGAGGGGCTGGCTGCTTGGCTGCTGCTTTTATTCACACTTGTTCAGGGAGAGCA 2161 CAGAGAATACCCTTCAGCATGGCCACTCTGGACCCAAGAGGAGGAAAAAACGGAAGCTTTTTTAGGAGAAGGAGGACTTG 2241 CTGGAATCCAAGATGTGAAGAACTCTTGGTGACTGGCTGGCTGGCCAGCGGGCACCACACCTGCACTTGAGTGCCTCGGG 2321 CTTGCTTATTAATAACGCACAGAAGAAGCATCACTTCTCACCATCTCCTGGCATGTATGGAGCAGGGAGCAAGGCTATGT 2401 TCCCGAAAGCCCTGATTAGCTTGTCTTGCTCTACGCTCGACCTCGAACAATACAGCTTGTAAGACCTCAGTCAGTCCTGG 2481 TACACTGGGGTAAATCAGTGTGGTGGTGGAAGAAAAGCCGGGAGGCCTATTTTTATAGGAAAATAGTACCATTAAAGGTG 2561 CAATGCTGTCATTTTGGACAAAAGGAAAGAAATTTGGAAGAGCTGGGATTATTGGCAAAAACTTGCTGAGGGGTGAATCT 2641 TTAGAGCTAATCACTGCAGAATCAGAGTTGCAGCAATATGATTGCAAGCAAGTCTGAATGCATAGTTTTACTTTAATTCG 2721 GCTTGACAATTTGAATAGGTAACCCCCTCGGGACTGACTGAATCGTTATGCATGTGTCAATCAATGGGAGGTGTGCATTC 2801 TCTAGAAGTAGTTTTAGGCTGTTTGGTTTGGTTTTGGTTTTGTTTTTTAAATGCAGCCTGTTGAGGCACTGTCATGTGGT 2881 GTGAAAGATTTAAATGTAGCAACGCTAAAGAGTAATAATTTGGGGATAAGAAGTGGGGACATTGGCCGGGCGCGGTGGCT 2961 CACGCCTGTAATTCCAGCACTTTGGGAGGCCTAGGTGGGCGGATCAGCTGAGGTCGAGAGTTCGAGGCCAGTCTGACCAA 3041 CATGGTGAAACCCCATCTCTACTAAAAATACAGAAAATTAGCTGGGTCTGGTGGTGGATGCCTGTAATCCCAGCTACTCG 3121 GGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGTGGACGGTGCAGTGAGCTATTACTCCAGCCTGGGCAACAAGAG 3201 CGAAACTCTGTCTCAAAAAAAAAAAGGGGGGGGGGGGACATTAAGAGAGTGGTGATGACCCAAATGTTGAACCAATTATG 3281 TTTTGGTGGTGGTGTTCTTAGCTGTTGAATCCTGAATGGTTTATAAAGTGAACTAGCTGGCTTAATGCAGCCAGCGTTCT 3361 GGGCAGCAGAACATATTCATTCTTACTGTAAATTCTATTTGCTGCTTCCAAAGGTGATGATTTTCAAGCAGACATGTTCT 3441 ATATGGTCTGTGTTTTAGGATCTGGTGCCCAGCCTCTATCAGAGCTTGCCTACCTGGCAAAGCTGCCTACCCTTCAAGTG 3521 GGAAAATATAATCCACTGTTTAACAAGGCTCACCCTCTCCACCCTGTCCTAACGACCTTTTGTGAATGTGCTGTGATATT 3601 TTCTTGCTCAATAGCAAGGTGGTAGCTCTGCTTTCATTTTAAGAAAGTGGAGGCTGAGGGCATTGTATCAATACTGTTGC 3681 AACTCCAAGAAGTTTTCCTTGTAAAATTAAAGGAAAGATCTTGTTATTGATTAACCATTTTCTTATGCCTTGCTATTGAC 3761 ATATTCATGCTCTTTCTACGTCTAGTGGCTGAAAATGTTTGCATTTGTTCATTTGACTAATGGTGTGATTTTTGTTTCTA 3841 TATTATTAGACCTGTAATGTTTTAAAATGTATTTTATTAAATTTGGACTGGATGTATGTCTCTAGCAATACGAGGTACTT 3921 TCTAAACTATTAAGGGAGGGGTTGTATCCTCATGTTGAGATAAGATGATGGTCGTTTAAATTTTGCAATTTTTTTTGGCC 4001 TGCAGGGATATTTTGTGTTTATGTGTCCAAAAAAGGAATAAATTGGCATTCTTGTGCCAAAAGTTGTTTTTCCTGTCAAT 4081 TGTCTAATAAGTATGCAGTACACTGTAATGGCAACATACATGGTTGCTTTATAAAAACAGTTTCCTCAGTATGAGAAATT 4161 TTACAAAGAACAGTGGAAAAACTTTGTGTTTTTAACTCTTGGGTCTCCCTATTTTTAAAAATTGCTATTTGGTATACAAT 4241 TATTATGTGTCAATTAAAACTAAAATAAAACTTTTAAAAAAGAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000373210.3 | 3UTR | UUGGCAAUAAACAUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000373210.3 | 3UTR | UUGGCAAUAAACAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
140 hsa-miR-137 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT002489 | E2F6 | E2F transcription factor 6 | 4 | 1 | ||||||||
MIRT002490 | CDK6 | cyclin dependent kinase 6 | 4 | 7 | ||||||||
MIRT004004 | NCOA2 | nuclear receptor coactivator 2 | 4 | 1 | ||||||||
MIRT004579 | KDM1A | lysine demethylase 1A | 5 | 3 | ||||||||
MIRT005485 | CDC42 | cell division cycle 42 | 4 | 4 | ||||||||
MIRT005605 | CTBP1 | C-terminal binding protein 1 | 4 | 1 | ||||||||
MIRT005883 | MITF | melanogenesis associated transcription factor | 3 | 1 | ||||||||
MIRT006329 | PTGS2 | prostaglandin-endoperoxide synthase 2 | 2 | 1 | ||||||||
MIRT006957 | ESRRA | estrogen related receptor alpha | 1 | 1 | ||||||||
MIRT007068 | ZNF804A | zinc finger protein 804A | 1 | 1 | ||||||||
MIRT007092 | YBX1 | Y-box binding protein 1 | 3 | 3 | ||||||||
MIRT007252 | CSE1L | chromosome segregation 1 like | 2 | 1 | ||||||||
MIRT007346 | PXN | paxillin | 3 | 1 | ||||||||
MIRT053056 | GLIPR1 | GLI pathogenesis related 1 | 3 | 1 | ||||||||
MIRT053225 | MET | MET proto-oncogene, receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT054547 | FUNDC1 | FUN14 domain containing 1 | 3 | 1 | ||||||||
MIRT054568 | BNIP3L | BCL2 interacting protein 3 like | 3 | 1 | ||||||||
MIRT090615 | PLS1 | plastin 1 | 2 | 2 | ||||||||
MIRT093393 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT109230 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 6 | ||||||||
MIRT153687 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT170929 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT219251 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT259552 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT271869 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT280623 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 8 | ||||||||
MIRT293284 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT314017 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | 2 | 8 | ||||||||
MIRT374677 | AGO4 | argonaute 4, RISC catalytic component | 2 | 2 | ||||||||
MIRT437385 | FMNL2 | formin like 2 | 1 | 1 | ||||||||
MIRT437406 | RORA | RAR related orphan receptor A | 1 | 1 | ||||||||
MIRT437423 | KIT | KIT proto-oncogene receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT437424 | AKT2 | AKT serine/threonine kinase 2 | 5 | 4 | ||||||||
MIRT437425 | TGFB2 | transforming growth factor beta 2 | 3 | 1 | ||||||||
MIRT437804 | SERPINA3 | serpin family A member 3 | 1 | 1 | ||||||||
MIRT437978 | COX2 | cytochrome c oxidase subunit II | 3 | 1 | ||||||||
MIRT438078 | TRIM13 | tripartite motif containing 13 | 4 | 1 | ||||||||
MIRT438287 | TBX3 | T-box 3 | 1 | 1 | ||||||||
MIRT438288 | KLF4 | Kruppel like factor 4 | 1 | 1 | ||||||||
MIRT438537 | MTDH | metadherin | 2 | 1 | ||||||||
MIRT438757 | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 | 2 | 1 | ||||||||
MIRT442564 | CCDC59 | coiled-coil domain containing 59 | 2 | 2 | ||||||||
MIRT442778 | JAG1 | jagged 1 | 2 | 2 | ||||||||
MIRT444302 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT446969 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT448824 | FKBP1A | FK506 binding protein 1A | 2 | 4 | ||||||||
MIRT453617 | SNRPE | small nuclear ribonucleoprotein polypeptide E | 2 | 4 | ||||||||
MIRT459217 | MRPS21 | mitochondrial ribosomal protein S21 | 2 | 2 | ||||||||
MIRT463490 | ZC3H11A | zinc finger CCCH-type containing 11A | 2 | 12 | ||||||||
MIRT470084 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT475876 | H3F3C | H3 histone family member 3C | 2 | 10 | ||||||||
MIRT475912 | H3F3B | H3 histone family member 3B | 2 | 8 | ||||||||
MIRT476669 | FUT11 | fucosyltransferase 11 | 2 | 10 | ||||||||
MIRT477346 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT477596 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 10 | ||||||||
MIRT478367 | DDI2 | DNA damage inducible 1 homolog 2 | 2 | 2 | ||||||||
MIRT479111 | CNN2 | calponin 2 | 2 | 2 | ||||||||
MIRT482926 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT485083 | SNRK | SNF related kinase | 2 | 12 | ||||||||
MIRT497120 | NBEAL1 | neurobeachin like 1 | 2 | 2 | ||||||||
MIRT498029 | UBXN4 | UBX domain protein 4 | 2 | 8 | ||||||||
MIRT500603 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 4 | ||||||||
MIRT500927 | SSFA2 | sperm specific antigen 2 | 2 | 8 | ||||||||
MIRT504324 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT504647 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT506304 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 6 | ||||||||
MIRT508007 | BCAT1 | branched chain amino acid transaminase 1 | 2 | 4 | ||||||||
MIRT510538 | XKR7 | XK related 7 | 2 | 2 | ||||||||
MIRT513051 | LYPD6 | LY6/PLAUR domain containing 6 | 2 | 6 | ||||||||
MIRT515223 | COX20 | COX20, cytochrome c oxidase assembly factor | 2 | 8 | ||||||||
MIRT519857 | ZFP62 | ZFP62 zinc finger protein | 2 | 6 | ||||||||
MIRT520508 | TRAM2 | translocation associated membrane protein 2 | 2 | 6 | ||||||||
MIRT522047 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 4 | ||||||||
MIRT524479 | CHRM3 | cholinergic receptor muscarinic 3 | 2 | 4 | ||||||||
MIRT526904 | ZNF772 | zinc finger protein 772 | 2 | 6 | ||||||||
MIRT527862 | SLC39A14 | solute carrier family 39 member 14 | 2 | 2 | ||||||||
MIRT528601 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT532950 | ZNF24 | zinc finger protein 24 | 2 | 4 | ||||||||
MIRT536275 | LMOD2 | leiomodin 2 | 2 | 2 | ||||||||
MIRT537045 | GRAMD4 | GRAM domain containing 4 | 2 | 2 | ||||||||
MIRT537124 | GOLGA3 | golgin A3 | 2 | 4 | ||||||||
MIRT538884 | BTBD1 | BTB domain containing 1 | 2 | 2 | ||||||||
MIRT541457 | AURKA | aurora kinase A | 2 | 2 | ||||||||
MIRT542924 | HOXC8 | homeobox C8 | 2 | 2 | ||||||||
MIRT544580 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT545175 | RFTN2 | raftlin family member 2 | 2 | 2 | ||||||||
MIRT545248 | GTF2E1 | general transcription factor IIE subunit 1 | 2 | 2 | ||||||||
MIRT546473 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT547523 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT548071 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT548200 | FNIP1 | folliculin interacting protein 1 | 2 | 2 | ||||||||
MIRT551216 | CIDEC | cell death inducing DFFA like effector c | 2 | 2 | ||||||||
MIRT553046 | USP28 | ubiquitin specific peptidase 28 | 2 | 2 | ||||||||
MIRT553875 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT554026 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT554153 | SLX4 | SLX4 structure-specific endonuclease subunit | 2 | 2 | ||||||||
MIRT554192 | SLC35E2B | solute carrier family 35 member E2B | 2 | 2 | ||||||||
MIRT554362 | SFXN5 | sideroflexin 5 | 2 | 4 | ||||||||
MIRT555349 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT555822 | PAX9 | paired box 9 | 2 | 2 | ||||||||
MIRT555866 | PAIP1 | poly(A) binding protein interacting protein 1 | 2 | 2 | ||||||||
MIRT555931 | NUP43 | nucleoporin 43 | 2 | 2 | ||||||||
MIRT555993 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT556429 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT556582 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 4 | ||||||||
MIRT557220 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | 2 | 2 | ||||||||
MIRT558490 | DBN1 | drebrin 1 | 2 | 2 | ||||||||
MIRT560986 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 2 | ||||||||
MIRT562291 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT564093 | TLR3 | toll like receptor 3 | 2 | 2 | ||||||||
MIRT565312 | TMEM41A | transmembrane protein 41A | 2 | 2 | ||||||||
MIRT565424 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT566946 | LIMCH1 | LIM and calponin homology domains 1 | 2 | 2 | ||||||||
MIRT572369 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT686211 | ZNF267 | zinc finger protein 267 | 2 | 2 | ||||||||
MIRT686935 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT687448 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT710856 | COQ7 | coenzyme Q7, hydroxylase | 2 | 2 | ||||||||
MIRT719484 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT719813 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT720076 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT723920 | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif 15 | 2 | 2 | ||||||||
MIRT731305 | CUL4A | cullin 4A | 3 | 1 | ||||||||
MIRT732128 | BMP7 | bone morphogenetic protein 7 | 2 | 1 | ||||||||
MIRT732466 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 3 | 0 | ||||||||
MIRT732962 | TNC | tenascin C | 1 | 0 | ||||||||
MIRT734856 | KDM4A | lysine demethylase 4A | 3 | 0 | ||||||||
MIRT735625 | MEF2A | myocyte enhancer factor 2A | 2 | 0 | ||||||||
MIRT735795 | IL6 | interleukin 6 | 3 | 0 | ||||||||
MIRT736333 | DELE1 | KIAA0141 | 2 | 0 | ||||||||
MIRT736610 | RUNX2 | runt related transcription factor 2 | 3 | 0 | ||||||||
MIRT736830 | NOTCH1 | notch 1 | 3 | 0 | ||||||||
MIRT736888 | KCNA2 | potassium voltage-gated channel subfamily A member 2 | 3 | 0 | ||||||||
MIRT737349 | EGFR | epidermal growth factor receptor | 3 | 0 | ||||||||
MIRT755368 | GLS | glutaminase | 2 | 1 | ||||||||
MIRT755431 | SPHK2 | sphingosine kinase 2 | 3 | 1 | ||||||||
MIRT756119 | USP30 | ubiquitin specific peptidase 30 | 4 | 1 | ||||||||
MIRT756144 | XIAP | X-linked inhibitor of apoptosis | 3 | 1 | ||||||||
MIRT756170 | COL5A1 | collagen type V alpha 1 chain | 3 | 1 | ||||||||
MIRT756171 | FSTL1 | follistatin like 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|